Press release
Human Papillomavirus Treatment Market 2034: Clinical Trials, EMA, PDMA, FDA Approvals, Prevalence, Statistics, Revenue, Therapies, Companies by DelveInsight
Human Papillomavirus Treatment Market
The latest 7MM report uncovers crucial epidemiological patterns, transformative market trends, and highlights leading innovators like VLP The Vaccines Company SL, Voltron Therapeutics Inc., Rubius Therapeutics, Bristol-Myers Squibb, Precigen Inc., and Privo Technologies-all shaping the future of HPV prevention and treatment.
Some of the key facts of the Human Papillomavirus Market Report:
• According to DelveInsight, the human papillomavirus market in the 7MM is expected to experience significant growth during the study period from 2020 to 2034.
• According to the CDC, HPV is the most common sexually transmitted infection in the United States, with an oral HPV prevalence of 7.3% and high-risk HPV at 4.0% among adults aged 18-69 during 2011-2014.
• A study by Han et al. (2017) found that genital HPV infection affected 45.2% of men in the NHANES 2013-2014 survey, with low HPV vaccination rates of 10.7%.
• Available literature indicates that genital HPV prevalence is higher in men than in women.
• In February 2025, Precigen, Inc. announced that the FDA accepted its biologics license application (BLA) for PRGN-2012, an investigational gene therapy designed to treat HPV 6 and HPV 11-associated recurrent respiratory papillomatosis (RRP). The therapy received priority review, with a PDUFA date set for August 27, 2025.
• PRGN-2012 is designed to elicit immune responses against HPV-infected cells and has received Breakthrough Therapy Designation, Orphan Drug Designation, and an accelerated approval pathway from the FDA.
• In May 2024, Roche received FDA approval for its HPV self-testing kit, enabling early detection and improved diagnosis of HPV-related diseases.
• Key therapies in development for HPV include STP909, RTX-321, BVAC-C, GX-188E, ITI-2000, VGX-3100, ISA101, and others.
• Leading companies in the HPV treatment landscape include Inovio Pharmaceuticals, ISA Pharmaceuticals, Regeneron Pharmaceuticals, Merck, Pattern Pharma, Nykode, Vaccibody A/S, Turnstone Biologics, Advaxis, AstraZeneca, VLP The Vaccines Company SL, Voltron Therapeutics Inc., Rubius Therapeutics, Bristol-Myers Squibb, Precigen Inc., Privo Technologies, ViciniVax BV, Avalia Immunotherapies, BlueSky Immunotherapies, Cellid Co. Ltd, Cue Biopharma, Cullinan Oncology, Genexine, EyeGene, Hookipa Pharma, Immunomic Therapeutics, SQZ Biotechnologies, and others.
Request a sample to explore key market trends and future opportunities in the evolving human papillomavirus landscape across the 7MM @ https://www.delveinsight.com/sample-request/human-papillomavirus-hpv-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr
Human Papillomavirus Overview
Human Papillomavirus (HPV) is a group of more than 200 related viruses, many of which can infect the skin and mucous membranes. Some strains of HPV can lead to benign warts, while others are associated with various cancers, including cervical, anal, and oropharyngeal cancers. HPV is primarily transmitted through sexual contact and is one of the most common sexually transmitted infections worldwide. Although most infections are asymptomatic and clear on their own, persistent infection with high-risk HPV types can lead to cancer. Vaccination and screening are key strategies in preventing HPV-related cancers.
Human Papillomavirus Epidemiology
The epidemiology section provides insights into the historical, current, and forecasted epidemiology trends in the seven major countries (7MM) from 2020 to 2034. It helps to recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. The epidemiology section also provides a detailed analysis of the diagnosed patient pool and future trends.
Download the report to understand which factors are driving human papillomavirus epidemiology trends @ https://www.delveinsight.com/report-store/human-papillomavirus-hpv-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr
Human Papillomavirus Drugs Uptake and Pipeline Development Activities
The drugs uptake section focuses on the rate of uptake of the potential drugs recently launched in the Human Papillomavirus market or expected to be launched during the study period. The analysis covers the Human Papillomavirus market uptake by drugs, patient uptake by therapies, and sales of each drug.
Moreover, the therapeutics assessment section helps understand the drugs with the most rapid uptake and the reasons behind the maximal use of the drugs. Additionally, it compares the drugs based on market share.
The report also covers the human papillomavirus pipeline development activities. It provides valuable insights about different therapeutic candidates in various stages and the key companies involved in developing targeted therapeutics. It also analyzes recent collaborations, acquisitions, mergers, licensing patent details, and other information for emerging therapies.
To know in detail about the human papillomavirus market outlook, drug uptake, treatment scenario, and epidemiology trends, Click here: https://www.delveinsight.com/report-store/human-papillomavirus-hpv-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr
Human Papillomavirus Market Strengths
• The availability of HPV vaccines, such as Gardasil, which offer protection against the most dangerous strains of the virus, is a significant strength in managing and preventing HPV-related diseases.
• Growing public health awareness about HPV's role in cancer prevention and the benefits of vaccination has led to higher vaccination rates, particularly among adolescents.
Human Papillomavirus Market Weaknesses
• Despite the effectiveness of vaccines, there are still regions, particularly in low- and middle-income countries, where access to HPV vaccination remains limited due to cost and infrastructure challenges.
• The stigma surrounding sexually transmitted infections like HPV can hinder individuals from seeking vaccination or screening, leading to lower prevention rates and delayed diagnoses.
Get a free sample for the human papillomavirus market Report: https://www.delveinsight.com/sample-request/human-papillomavirus-hpv-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr
Scope of the Human Papillomavirus Market Report
• Study Period: 2020-2034
• Coverage: 7MM [The United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan]
• Key Human Papillomavirus Therapies: STP909, RTX-321, BVAC-C, GX-188E, ITI-2000, VGX-3100, ISA101, and others.
• Key Human Papillomavirus Companies: Inovio Pharmaceuticals, ISA Pharmaceuticals, Regeneron Pharmaceuticals, Merck, Pattern Pharma, Nykode, Vaccibody A/S, Turnstone Biologics, Advaxis, AstraZeneca, VLP The Vaccines Company SL, Voltron Therapeutics Inc., Rubius Therapeutics, Bristol-Myers Squibb, Precigen Inc., Privo Technologies, ViciniVax BV, Avalia Immunotherapies, BlueSky Immunotherapies, Cellid Co. Ltd, Cue Biopharma, Cullinan Oncology, Genexine, EyeGene, Hookipa Pharma, Immunomic Therapeutics, SQZ Biotechnologies, and others.
• Human Papillomavirus Therapeutic Assessment: Human Papillomavirus currently marketed and Human Papillomavirus emerging therapies
• Human Papillomavirus Market Dynamics: Human Papillomavirus market drivers and Human Papillomavirus market barriers
• Competitive Intelligence Analysis: SWOT analysis, PESTLE analysis, Porter's five forces, BCG Matrix, Market entry strategies
• Human Papillomavirus Unmet Needs, KOL's views, Analyst's views, Human Papillomavirus Market Access and Reimbursement
To learn more about the key players and advancements in the human papillomavirus treatment Landscape, visit: https://www.delveinsight.com/sample-request/human-papillomavirus-hpv-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr
Table of Contents
1. Human Papillomavirus Market Report Introduction
2. Executive Summary for Human Papillomavirus
3. SWOT analysis of Human Papillomavirus
4. Human Papillomavirus Patient Share (%) Overview at a Glance
5. Human Papillomavirus Market Overview at a Glance
6. Human Papillomavirus Disease Background and Overview
7. Human Papillomavirus Epidemiology and Patient Population
8. Country-Specific Patient Population of Human Papillomavirus
9. Human Papillomavirus Current Treatment and Medical Practices
10. Human Papillomavirus Unmet Needs
11. Human Papillomavirus Emerging Therapies
12. Human Papillomavirus Market Outlook
13. Country-Wise Human Papillomavirus Market Analysis (2020-2034)
14. Human Papillomavirus Market Access and Reimbursement of Therapies
15. Human Papillomavirus Market Drivers
16. Human Papillomavirus Market Barriers
17. Human Papillomavirus Appendix
18. Human Papillomavirus Report Methodology
19. DelveInsight Capabilities
20. Disclaimer
21. About DelveInsight
Related Reports:
• Ventricular Fibrillation Market: https://www.delveinsight.com/report-store/supraventricular-tachycardia-market
• Acute Pulmonary Embolism Market: https://www.delveinsight.com/report-store/acute-pulmonary-embolism-market
• Human Papilomavirus Market: https://www.delveinsight.com/report-store/human-papillomavirus-hpv-market
• Acoustic Neuroma Market: https://www.delveinsight.com/report-store/acoustic-neuroma-market
• Fibrocystic Breast Condition Market: https://www.delveinsight.com/report-store/fibrocystic-breast-condition-market
• Ventricular Dysfunction Market: https://www.delveinsight.com/report-store/ventricular-dysfunction-market
• Immunologic Deficiency Syndrome Market: https://www.delveinsight.com/report-store/immunologic-deficiency-syndrome-market
• Healthcare Competitive Benchmarking: https://www.delveinsight.com/consulting/competitive-benchmarking-services
• Age-related Macular Degeneration Market: https://www.delveinsight.com/report-store/age-related-macular-degeneration-amd-market
• Interbody Cages Market: https://www.delveinsight.com/report-store/interbody-cages-market
• Burn Market: https://www.delveinsight.com/report-store/burns-market
• Hearing Implants Market: https://www.delveinsight.com/report-store/hearing-implants-market
• Advanced Cancer Pain Management Market: https://www.delveinsight.com/report-store/advanced-cancer-pain-management-market
• Diabetic Nephropathy Market: https://www.delveinsight.com/report-store/diabetic-nephropathy-market
• Dyspnea Market: https://www.delveinsight.com/report-store/dyspnea-market
• Eczema Market: https://www.delveinsight.com/report-store/eczema-market
• Implantable Infusion Pumps Market: https://www.delveinsight.com/report-store/implantable-infusion-pumps-market
• Menorrhalgia Market Size: https://www.delveinsight.com/report-store/menorrhalgia-market
• Pemphigus Vulgaris Market: https://www.delveinsight.com/report-store/pemphigus-vulgaris-market
• Tay-sachs Disease Or Gm2 Gangliosidosis Market: https://www.delveinsight.com/report-store/gm2-gangliosidosis-market
• Acute Lung Injury Market: https://www.delveinsight.com/report-store/acute-lung-injury-market
• Acute Radiation Syndrome Market: https://www.delveinsight.com/report-store/acute-radiation-syndrome-market
• Aids Related Kaposi's Sarcoma Market: https://www.delveinsight.com/report-store/aids-related-kaposis-sarcoma-market
• Anemia In Ckd Market: https://www.delveinsight.com/report-store/anemia-in-chronic-kidney-disease-market
• Aortic Aneurysm Stent Grafts Market: https://www.delveinsight.com/report-store/aortic-aneurysm-stent-grafts-market
Contact Us:
Ankit Nigam
Manager Marketing
info@delveinsight.com
+14699457679
https://www.delveinsight.com/consulting
About DelveInsight
DelveInsight is a leading Life Science market research and business consulting company recognized for its off-the-shelf syndicated market research reports and customized solutions to firms in the healthcare sector.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Human Papillomavirus Treatment Market 2034: Clinical Trials, EMA, PDMA, FDA Approvals, Prevalence, Statistics, Revenue, Therapies, Companies by DelveInsight here
News-ID: 4091724 • Views: …
More Releases from DelveInsight Business Research
Short Bowel Syndrome Market on Track for Major Expansion by 2034, According to D …
DelveInsight's "Short Bowel Syndrome Market Insights, Epidemiology, and Market Forecast-2034′′ report offers an in-depth understanding of the Short Bowel Syndrome, historical and forecasted epidemiology as well as the Short Bowel Syndrome market trends in the United States, EU4 (Germany, Spain, Italy, France) the United Kingdom and Japan.
To Know in detail about the Short Bowel Syndrome market outlook, drug uptake, treatment scenario and epidemiology trends, Click here; Short Bowel Syndrome…
Gastroparesis Market Forecasted to Surge in Coming Years, 2024-2034 Analysis by …
DelveInsight's "Gastroparesis Market Insights, Epidemiology, and Market Forecast-2034′′ report offers an in-depth understanding of the Gastroparesis, historical and forecasted epidemiology as well as the Gastroparesis market trends in the United States, EU4 (Germany, Spain, Italy, France) the United Kingdom and Japan.
To Know in detail about the Gastroparesis market outlook, drug uptake, treatment scenario and epidemiology trends, Click here; Gastroparesis Market Forecast
https://www.delveinsight.com/sample-request/gastroparesis-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
Some of the key facts of the Gastroparesis…
Uveitis Pipeline 2025: Therapies, MOA Insights, and Key Clinical Trial Updates b …
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Uveitis pipeline constitutes 15+ key companies continuously working towards developing 15+ Uveitis treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight.
"Uveitis Pipeline Insight, 2025" report by DelveInsight outlines comprehensive insights into the present clinical development scenario and growth prospects across the Uveitis Market.
The Uveitis Pipeline report embraces in-depth…
Aplastic Anemia Market Expected to Experience Major Growth by 2034, According to …
DelveInsight's "Aplastic Anemia Market Insights, Epidemiology, and Market Forecast-2034′′ report offers an in-depth understanding of the Aplastic Anemia, historical and forecasted epidemiology as well as the Aplastic Anemia market trends in the United States, EU4 (Germany, Spain, Italy, France, and United Kingdom) and Japan.
To Know in detail about the Aplastic Anemia market outlook, drug uptake, treatment scenario and epidemiology trends, Click here; Aplastic Anemia Market Forecast
https://www.delveinsight.com/report-store/aplastic-anemia-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
Some of the…
More Releases for Human
Mooka: Replacing Human Error with AI - Not Human Connection
Salt Lake City, UT - October 21, 2025 - In an era where automation and artificial intelligence are reshaping nearly every corner of online retail, Mooka [https://www.mooka.io/], a leader in eCommerce automation and marketplace optimization, is taking a clear stand: AI should replace human error, not human interaction.
As eCommerce continues to scale, many sellers face a growing challenge-how to keep operations efficient while preserving the human touch that builds trust,…
Tennessee United for Human Rights Challenging Hate this Human Rights Day
Nashville, Tennessee, 10th October 2025, ZEX PR WIRE, Tennessee United for Human Rights (TNUHR) coordinates with human rights agencies across the state to organize the annual Human Rights Day celebration, set for December 10, 2025, in Nashville, Tennessee.
This year's theme, "Challenging Hate: Standing Together for Universal Human Rights," reflects the ongoing commitment of local organizations to unite communities, confront prejudice, and promote equality and understanding for all.
The celebration will honor…
Global Human Augmentation Market 2024-2031: Advancing Human Potential Through Te …
Global Human Augmentation Market reached US$ 252.6 Billion in 2023 and is expected to reach US$ 780.7 Billion by 2031, growing with a CAGR of 15.6% during the forecast period 2024-2031.
The Human Augmentation Market focuses on technologies enhancing human capabilities through wearable exoskeletons, neural interfaces, prosthetics, and performance-enhancing devices. Growth is fueled by medical rehabilitation, industrial automation, defense applications, and lifestyle technology. Advances in robotics, AI, and brain-computer interfaces expand…
Human Factors and Usability Engineering Services Market Key Players Analysis - H …
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Human Factors and Usability Engineering Services Market"-, By Steps Involved (Summative Study, Contextual Analysis, Formative Study, Known Use Error Analysis, Use Risk Analysis, Submission Preparation, Design Process and Task Analysis), By Type of Research Method (Evaluation Research and Generative Research), Class of Medical Device Tested (Class I, Class II and Class III ), Industry Trends, and…
Defending Human Life
Albert Covarrubias, Jr was fighting for his Constitutional rights and was killed in the line of duty by his own police force. There is no divine right to kill him for simply standing up for his rights. Every person has the right to stand for what they believe, rather than be gunned down. You cannot take away human life as being ok with simply saying it was a mistake.
If someone…
I AM HUMAN
Camerata Europæa (CE), inspired by the kaleidoscope of unique current events in the world, presents a cultural program for the year 2022/23 under the motto I AM HUMAN. New perceptions, new morals, new technologies, and ultimately a whole new world, shape modern man. With the progress of science and the evolution of technology, man has comprehended previously unimaginable concepts, marking great and admirable achievements. However, the powerful mechanisms of modern…
